MindImmune Therapeutics

0 followers

MindImmune Therapeutics, Inc. is a pharmaceutical company developing first-in-class drugs that target the immune system to treat diseases of the central nervous system, including Alzheimer’s and Huntington’s disease, pain, and psychiatric disorders.

Industries

Employees

1-10

Links


Org chart

Stevin Zorn
Founder and SeniorExecutive Advisor
Collapse
Keri Drew
Corporate Controller
Robert B. Nelson
VP, Biology & Corporate Secretary
Joseph Hedde
Research Director
Kenneth Rose, Ph.D.
Director of Translational Science
Thomas Prod'homme
Vice President, Preclinical Development
Rob Berman
Scientific and Medical Advisor
Leonid Gorelik
Chief Scientific Officer

Board & advisors


Teams

This company has no teams yet